Lamivudine
10 mg/ml, 240 ml № 1
Pharmacotherapeutic group
Active ingredient
Pharmaceutical form
Oral solution
ATC code
J05А F05
RX/OTC
RX
Registration certificate
UA/13630/01/01
General properties
Pharmacotherapeutic group
Antiviral medication of direct action. Nucleoside and nucleotide reverse transcriptase inhibitors. Lamivudine.
Therapeutic indications
Lamivudine in combination with other antiretroviral agents is indicated for the treatment of HIV infection.
Contraindications
Hypersensitivity to lamivudine or other components of the drug.
Pharmaceutical characteristics
Main physicochemical properties
Сlear colorless or light yellow liquid with fruit odor.
Shelf life
2 years.
Storage
Store in the original packaging at temperature not exceeding 25 0C.
Keep out of reach of children.
Manufacturer
PJSC «Technolog».
Location
Ukraine, 20300, Cherkassy region, Uman, Stara Prorizna Str., building 8.
